Zobrazeno 1 - 10
of 10
pro vyhledávání: '"A. M. E. Stades"'
Autor:
Ingrid M. Zandbergen, Amir H. Zamanipoor Najafabadi, Iris C. M. Pelsma, M. Elske van den Akker-van Marle, Peter H. L. T. Bisschop, H. D. Jeroen Boogaarts, Arianne C. van Bon, Bakhtyar Burhani, Saskia le Cessie, Olaf M. Dekkers, Madeleine L. Drent, Richard A. Feelders, Johan P. de Graaf, J. Hoogmoed, Kitty K. Kapiteijn, Melanie M. van der Klauw, Willy-Anne C. M. Nieuwlaat, Alberto M. Pereira, Aline M. E. Stades, Annenienke C. van de Ven, Iris M. M. J. Wakelkamp, Wouter R. van Furth, Nienke R. Biermasz, on behalf of the Dutch Prolactinoma Study Group
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background First-line treatment for prolactinomas is a medical treatment with dopamine agonists (DAs), which effectively control hyperprolactinaemia in most patients, although post-withdrawal remission rates are approximately 34%. Therefore,
Externí odkaz:
https://doaj.org/article/1666f094fa3f43fd86206fba8afb06e3
Autor:
Brian M. Frier, R. Zwertbroek, J. J. Holst, Joost B. L. Hoekstra, A. M. E. Stades, Mariëtte T. Ackermans, Filip K. Knop, Frits Holleman, J. J. J. de Sonnaville, Josefine E. Schopman, B. Hartmann
Publikováno v:
Diabetes, obesity & metabolism, 17(6), 546-553. Wiley-Blackwell
Aims To assess whether the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin affects glucagon and other counter-regulatory hormone responses to hypoglycaemia in patients with type 1 diabetes. Methods We conducted a single-centre, randomized, doubl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d5de7e140926995040ceca1d0acc04
https://doi.org/10.1111/dom.12453
https://doi.org/10.1111/dom.12453
Publikováno v:
The Netherlands journal of medicine. 75(10)
A 69-year-old man presented with leptomeningeally metastasised pituitary carcinoma, rapidly progressing despite previous treatment with resection, radiotherapy and cabergoline. The patient received temozolomide chemotherapy, resulting in a complete c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e44556cb0d72fb65c561137aaaffc79b
https://pubmed.ncbi.nlm.nih.gov/29256415
https://pubmed.ncbi.nlm.nih.gov/29256415
Publikováno v:
Clinical Endocrinology, 80(2), 184-190. Wiley-Blackwell
Van Den Bosch, O F C, Stades, A M E & Zelissen, P M J 2014, ' Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease ', Clinical Endocrinology, vol. 80, no. 2, pp. 184-190 . https://doi.org/10.1111/cen.12286
Van Den Bosch, O F C, Stades, A M E & Zelissen, P M J 2014, ' Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease ', Clinical Endocrinology, vol. 80, no. 2, pp. 184-190 . https://doi.org/10.1111/cen.12286
SummaryObjective In the last decade, pre-operative medical cortisol suppression therapy has frequently been used in Cushing's disease to normalize cortisol concentrations pre-operatively. Our aim was to assess the efficacy of presurgical medical cort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcf45bdea642fac2db6d73c687dd47c
https://doi.org/10.1111/cen.12286
https://doi.org/10.1111/cen.12286
Publikováno v:
European Journal of Endocrinology, 162(4), 667-75. Bioscientifica Ltd
BackgroundCabergoline, a dopamine agonist used to treat hyperprolactinemia, is associated with an increased risk of fibrotic adverse reactions, e.g. cardiac valvular fibrosis, pleuropulmonary, and retroperitoneal fibrosis.ObjectiveThis study evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af0cf61b70e8894463aea31ef8962a0
https://doi.org/10.1530/eje-09-0989
https://doi.org/10.1530/eje-09-0989
Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study
Publikováno v:
Netherlands journal of medicine, 56(3), 86-90. Van Zuiden Communications BV
INTRODUCTION: Recently the UKPDS study revealed the potency of metformin therapy in obese type 2 diabetic patients. A retrospective study was performed to assess the efficacy of metformin therapy in improving metabolic control in everyday practice. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadfd929e808103c97adb05d7ca1370e
https://doi.org/10.1016/s0300-2977(99)00128-x
https://doi.org/10.1016/s0300-2977(99)00128-x
Publikováno v:
Journal of internal medicine, 256(4). Wiley-Blackwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003169a46a34921d042bf680ed1409d5
https://pubmed.ncbi.nlm.nih.gov/15367179
https://pubmed.ncbi.nlm.nih.gov/15367179
Publikováno v:
Journal of internal medicine. 255(2)
Objective. Metformin has been associated with the serious side-effect lactic acidosis. However, it remains unclear whether the use of metformin was a cause or a coincidence in lactic acidosis. Design. A literature search of the Index Medicus (1959-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee18fe8dc47023bf7792074ceb7ab13
https://pubmed.ncbi.nlm.nih.gov/14746555
https://pubmed.ncbi.nlm.nih.gov/14746555
Autor:
Aline M E, Stades, Joost B L, Hoekstra, Ingeborg, van den Tweel, D Willem, Erkelens, Frits, Holleman
Publikováno v:
Diabetes care. 25(4)
This study was performed to evaluate whether an additional dose of NPH insulin at lunchtime might overcome the deleterious effects of waning basal insulinemia on pre-dinner and evening glucose values during insulin lispro intensive therapy with once
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4b5fd3098955c5d367819efa268d0869
https://pubmed.ncbi.nlm.nih.gov/11919130
https://pubmed.ncbi.nlm.nih.gov/11919130
Publikováno v:
L'Endocrinologo. 14:232-232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2a9640657b817327baae92ea765a7d5
https://doi.org/10.1007/bf03346103
https://doi.org/10.1007/bf03346103